Markets:

Overview

News

Currencies

International

Treasuries

Baxter International (NY:BAX)

20.02 +0.78 (+4.05%)

Streaming Delayed Price Updated: 2:48 PM EDT, Jun 9, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about Baxter International

< Previous 1 2

...

20 21 22 23 24 25 26 27 Next >

Baxter Announces $100 Million Investment in BioPharma Solutions Halle/Westfalen, Germany Sterile Fill/Finish Manufacturing Facility

November 11, 2021

From Baxter International Inc.

Via Business Wire

Here Are Answers for Shareholders After General Electric Breaks Up ↗

November 10, 2021

Larry Culp was hired to save GE in 2018, but finally decided to break it up in order to unlock what's left of its value, especially in the healthcare unit.

Via InvestorPlace

Baxter Highlights New Data Indicating Sharesource Digital Health Platform for Home Dialysis May Improve Survival and Reduce Hospitalizations

November 08, 2021

From Baxter International Inc.

Via Business Wire

Stock Profile: Baxter International Inc. ↗

September 11, 2021

Baxter International reported second-quarter sales increased a healthy 14% to $3.1 billion with net income increasing 22% to $301 million and EPS jumping 23% to $0.59.

Via Talk Markets

Baxter to Present at Evercore ISI 4th Annual HealthCONx Conference

November 02, 2021

From Baxter International Inc.

Via Business Wire

Baxter International Inc (BAX) Q2 2021 Earnings Call Transcript ↗

October 28, 2021

BAX earnings call for the period ending September 30, 2021.

Via The Motley Fool

Topics Earnings

Baxter Shares Fall Despite Better-Than-Expected Q3 Earnings, FY21 EPS Outlook Boost ↗

October 28, 2021

Baxter International Inc (NYSE: BAX) posted Q3 revenue of $3.23 billion, in line with the consensus, up 9% on a reported basis, 7% on a constant currency basis, and 6%...

Via Benzinga

The Daily Biotech Pulse: Merck Reports Beat-And-Raise Quarter, Pfizer-BioNTech Snag Orders For Additional Vaccine Doses, HCW Cleared For Phase 1 Study Of Pancreatic Cancer Drug ↗

October 28, 2021

Here's a roundup of top developments in the biotech space over the last 24 hours: Stocks In Focus Corvus' China Partner Approved For Early Stage Study Of CPI-818 In...

Via Benzinga

Baxter Reports Third-Quarter 2021 Results

October 28, 2021

From Baxter International Inc.

Via Business Wire

The Week Ahead In Biotech (Oct. 24-30): Eyenovia, ANI Pharma, Clearside Medical FDA Decisions, Merck, Bristol-Myers Squibb Earnings, IPOs And More ↗

October 24, 2021

Biotech stocks posted gains for the second week running, supported by multiple catalysts that included a good start to the big pharma reporting season and broader market strength...

Via Benzinga

Baxter and bioMérieux Announce CE Mark for NEPHROCLEAR™ CCL14 Test to Predict Persistent Severe Acute Kidney Injury

October 21, 2021

From Baxter International Inc. and bioMérieux

Via Business Wire

Baxter to Present at Credit Suisse 30th Annual Virtual Healthcare Conference

October 13, 2021

From Baxter International Inc.

Via Business Wire

Baxter Presents Critical Care Data at 34th Annual European Society of Intensive Care Medicine LIVES Congress

October 05, 2021

From Baxter International Inc.

Via Business Wire

Baxter to Host Third-Quarter 2021 Financial Results Conference Call for Investors

September 27, 2021

From Baxter International Inc.

Via Business Wire

Baxter's Norepinephrine Wins FDA Nod For Low Blood Pressure ↗

September 23, 2021

The FDA has approved Baxter International Inc's (NYSE: BAX) premix norepinephrine bitartrate in 5% dextrose injection. Norepinephrine is indicated to raise blood pressure in...

Via Benzinga

Baxter Announces U.S. FDA Approval and Launch of Ready-to-use Cardiovascular Medicine Norepinephrine in Premix Formulation

September 23, 2021

From Baxter International Inc.

Via Business Wire

Benzinga's Top Ratings Upgrades, Downgrades For September 3, 2021 ↗

September 03, 2021

Upgrades Barclays upgraded the previous rating for Baxter International Inc (NYSE:

Via Benzinga

Price To Earnings Ratio Insights For Baxter Intl ↗

September 02, 2021

Looking into the current session, Baxter Intl Inc. (NYSE:BAX) shares are trading at $82.22, after a 5.95% rise. Moreover, over the past month, the stock spiked by 10...

Via Benzinga

Benzinga's Top Ratings Upgrades, Downgrades For September 13, 2021 ↗

September 13, 2021

Upgrades For Bank of America Corp (NYSE:

Via Benzinga

Baxter to Acquire Hillrom At $156/Share: See The Highlights ↗

September 02, 2021

Baxter International Inc (NYSE: BAX) has agreed to acquire Hill-Rom Holdings Inc (NYSE: HRC) for $156.00 per share in cash, slightly higher than the earlier...

Via Benzinga

Baxter to Acquire Hillrom, Expanding Connected Care and Medical Innovation Globally

September 02, 2021

From Baxter International Inc.

Via Business Wire

2 Little-Followed Stocks That Are Soaring Monday ↗

August 30, 2021

Markets were on the rise overall, but these companies were surprising in their gains.

Via The Motley Fool

Topics Stocks

Why Shares of Hill-Rom Holdings Are Surging This Morning ↗

August 30, 2021

A previous buyout offer gets raised.

Via The Motley Fool

Baxter In Advanced Talks For $10B Hill Rom Buyout: WSJ ↗

August 30, 2021

The Wall Street Journal reported that Baxter International Inc (NYSE: BAX) is reportedly in advanced talks to Hill-Rom Holdings Inc (NYSE: HRC) for...

Via Benzinga

Baxter International Inc (BAX) Under Pressure, Here’s The Trade ↗

August 26, 2021

Baxter International Inc stock is now trading below its 200-week moving average. This puts the stock in a weak technical position on the charts and indicates lower stock prices ahead.

Via Talk Markets

Stocks That Hit 52-Week Lows On Thursday ↗

August 26, 2021

During Thursday's morning session, 21 companies made new 52-week lows. Interesting Highlights: Baxter Intl (NYSE:BAX) was the largest company by market cap to...

Via Benzinga

The Baxter International Foundation and UNICEF USA Announce Partnership to Improve Water Security in Colombia

August 18, 2021

From Baxter International Inc.

Via Business Wire

Baxter Recalls Dose IQ Software 9.0.x Used With Infusion Pumps ↗

August 13, 2021

The FDA issued a Class I recall, the most serious kind of recall, for Baxter International Inc's (NYSE: BAX) Dose IQ safety software used with Spectrum IQ...

Via Benzinga

Topics Product Recall

Got $5,000? These 3 Solid Dividend Stocks Are Trading Near Their 52-Week Lows ↗

August 11, 2021

If you're an income investor, these investments should be on your radar right now.

Via The Motley Fool

The Daily Biotech Pulse: Moderna's Vaccine Produces Durable Response Against Variants, FDA Approves Jazz's Sleep Disorder Drug, Dermata IPO ↗

August 13, 2021

Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Aug. 12) Adagio Therapeutics, Inc. (...

Via Benzinga

< Previous 1 2

...

20 21 22 23 24 25 26 27 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.